Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A RANDOMIZED, MULTICENTER, LONG TERM STUDY OF THE SAFETY OF TANEZUMAB IN PATIENTS WITH CHRONIC LOW BACK PAIN

NCT00924664 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00924664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00924664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A RANDOMIZED, MULTICENTER, LONG TERM STUDY OF THE SAFETY OF TANEZUMAB IN PATIENTS WITH CHRONIC LOW BACK PAIN
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Terminated
Start date
August 20, 2009
Completion date
June 22, 2011
Enrollment
849 (actual)
Sites
149

Conditions

As the registry lists them; a condition with its own page is linked.

low back pain